Corcept Therapeutics (CORT) Cash from Investing Activities (QoQ) (2012 - 2026)
Corcept Therapeutics (CORT) Cash from Investing Activities (QoQ) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Corcept Therapeutics |
8.35 Bn |
8.01 Bn |
162.02 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
138.35% |
| Dec 31, 2025 |
-180.87% |
| Sep 30, 2025 |
-79.12% |
| Jun 30, 2025 |
2,311.51% |
| Mar 31, 2025 |
95.07% |
| Dec 31, 2024 |
-46.15% |
| Sep 30, 2024 |
26.84% |
| Jun 30, 2024 |
-567.78% |
| Mar 31, 2024 |
-152.72% |
| Dec 31, 2023 |
115.60% |
| Sep 30, 2023 |
-354.70% |
| Jun 30, 2023 |
-111.61% |
| Mar 31, 2023 |
1,303.38% |
| Dec 31, 2022 |
-259.94% |
| Sep 30, 2022 |
88.54% |
| Jun 30, 2022 |
17.22% |
| Mar 31, 2022 |
-135.95% |
| Dec 31, 2021 |
644.40% |
| Sep 30, 2021 |
-204.29% |
| Jun 30, 2021 |
853.41% |
